Evidence map›Paper›PMID 25574764›Full record

ArticleJournal of medicinal chemistry2015

Antibacterial drug leads: DNA and enzyme multitargeting.

Wei Zhu, Yang Wang, Kai Li, Jian Gao, Chun-Hsiang Huang, Chun-Chi Chen, Tzu-Ping Ko, Yonghui Zhang, Rey-Ting Guo, Eric Oldfield

Abstract read
In one paragraph

Article in Journal of medicinal chemistry, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Escaping ESKAPE resistance:Royal Society open science · 2023
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Efficient O-Functionalization of Carbohydrates with Electrophilic Reagents.Angewandte Chemie (International ed. in English) · 2016
    Article
  14. Article
  15. Article
  16. Antagonism screen for inhibitors of bacterial cell wall biogenesis uncovers an inhibitor of undecaprenyl diphosphate synthase.Proceedings of the National Academy of Sciences of the United States of America · 2015
    Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Wei ZhuDepartment of Chemistry, University of Illinois at Urbana-Champaign , 600 South Mathews Avenue, Urbana, Illinois 61801, United States.
Yang Wang
Kai Li
Jian Gao
Chun-Hsiang Huang
Chun-Chi Chen
Tzu-Ping Ko
Yonghui Zhang
Rey-Ting Guo
Eric Oldfield

Funding

Structure, Function and Inhibition of [4Fe-4S] ProteinsR01GM065307 · NIGMS · UNIVERSITY OF ILLINOIS URBANA-CHAMPAIGN · PI OLDFIELD, ERIC · 2002 to 2017
$5.4M
NIGMS NIH HHS GM065307NIGMS NIH HHS R01 GM065307
6 · The paper itself

Abstract

We report the results of an investigation of the activity of a series of amidine and bisamidine compounds against Staphylococcus aureus and Escherichia coli. The most active compounds bound to an AT-rich DNA dodecamer (CGCGAATTCGCG)2 and using DSC were found to increase the melting transition by up to 24 °C. Several compounds also inhibited undecaprenyl diphosphate synthase (UPPS) with IC50 values of 100-500 nM, and we found good correlations (R(2) = 0.89, S. aureus; R(2) = 0.79, E. coli) between experimental and predicted cell growth inhibition by using DNA ΔTm and UPPS IC50 experimental results together with one computed descriptor. We also solved the structures of three bisamidines binding to DNA as well as three UPPS structures. Overall, the results are of general interest in the context of the development of resistance-resistant antibiotics that involve multitargeting.

Indexed as

Alkyl and Aryl TransferasesAmidinesAnti-Bacterial AgentsCell ProliferationDNA, BacterialDose-Response Relationship, DrugEscherichia coliMicrobial Sensitivity TestsMolecular StructureStaphylococcus aureusStructure-Activity RelationshipTemperatureAlkyl and Aryl TransferasesAmidinesAnti-Bacterial AgentsDNA, Bacterialundecaprenyl pyrophosphate synthetase

Identifiers

PMID25574764
PMCPMC4513954

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.